Bliss GVS Pharma’s marketing & distribution partner gets USFDA’s final approval for Mesalamine Suppositories

15 Apr 2025 Evaluate

Bliss GVS Pharma’s marketing and distribution partner -- Rising Pharma Holdings, Inc. USA has received final approval from the U.S. Food & Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) for the product ‘Mesalamine Suppositories 1000 mg’. The ANDA was submitted through the company’s partner in the USA. 

Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.


Bliss GVS Pharma Share Price

146.95 -3.50 (-2.33%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×